Sayre Therapeutics Overview
- Founded
-
2015

- Status
-
Private
- Employees
-
32

- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1M
- Investors
-
3
Sayre Therapeutics General Information
Description
Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The company's platform facilitates the development and registration of novel drugs, drug-delivery devices, and companion diagnostics, enabling pharmaceutical companies to commercialize proprietary drugs and medicines for the treatment of cancer.
Contact Information
Website
www.sayretherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- Number 91, 3rd Floor, G.R. Square
- Amarjyothi Nagar HBCS Layout, Inner Ring road, Domlur
- Bangalore, Karnataka 560071
- India
+91 080 0000 0000
Sayre Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Early Stage VC | 05-Sep-2017 | $1M | 00.00 | Completed | Generating Revenue | |
2. Early Stage VC | 04-Sep-2017 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
1. Early Stage VC (Series A) | 07-Apr-2015 | $3.97M | $3.97M | 00.000 | Completed | Generating Revenue |
Sayre Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Preference | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
Ordinary | 000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Preference | 79,800 | $0.156163 | $48.41 | $48.41 | 1x | $48.41 | 34.7% |
Sayre Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The co
Drug Discovery
Bangalore, India
32
As of 2022
00.00
0000000000 0
00.00
Sayre Therapeutics Competitors (4)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Invictus Oncology | Venture Capital-Backed | Delhi, India | 00 | 00.000 | 00000000000 | 00.000 |
000000 | Private Equity-Backed | Pune, India | 0000 | 00.000 | 00000000 | |
00000 000000000000 | Private Equity-Backed | Ahmedabad, India | 00000 | 000.00 | 00000000000 | 000.00 |
000 000000000000 | Venture Capital-Backed | Boston, MA | 00 | 000.00 | 0000000000 0 | 000.00 |
Sayre Therapeutics Executive Team (3)
Sayre Therapeutics Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Mahendran Balachandran | Accel | Board Member | 000 0000 |
Rajesh Sasidharan | Sayre Therapeutics | Head of Finance & Administration, Manager of Human resources & Administration & Board Member | 000 0000 |
Shukrit Chimote | Sayre Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Sayre Therapeutics Signals
Sayre Therapeutics Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
InnoVen Capital | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | |
Aarin Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Accel | Venture Capital | Minority | 000 0000 | 000000 0 |